Latest Strategy News

Tivan Limited has commenced its first drilling campaign at the Sandover Fluorite Project in the Northern Territory, aiming to define a commercially viable fluorite deposit with assay results expected in January 2026.

Reece Limited has announced a new on-market share buyback of up to $35 million, following its recent $365 million off-market buyback, signaling continued confidence in its capital management strategy.

Temas Resources has completed a major drilling campaign at its La Blache project, targeting key critical minerals while progressing its innovative Regenerative Chloride Leach technology promising significant cost savings.

DPM Metals has released a robust feasibility study for its Čoka Rakita gold project in Serbia, confirming strong economics with a $782 million net present value and a 36% internal rate of return at $1,900 per ounce gold. The study highlights increased reserves, low costs, and a clear path to production by 2029.

Argent Minerals has launched a major drilling campaign targeting silver, gold, and polymetallic mineralisation at its flagship Kempfield and Trunkey Creek projects in New South Wales.

Premier1 Lithium has significantly expanded a gold-in-soil anomaly at its Rochefort Prospect in Western Australia, confirming high-grade assays and revealing a larger prospective geological footprint. The company plans further targeted exploration in early 2026.

Neometals has released initial gold assay results from its Barrambie Ranges drilling program, revealing promising high-grade intercepts that reinforce the project's exploration potential while advancing the Ironclad deposit towards production.

Western Gold Resources reports strong, consistent high-grade gold results from the Golden Monarch deposit, reinforcing confidence in the Gold Duke Project’s early production and mine scheduling ahead of a planned Decision to Mine in late 2025.

Provaris Energy’s 2025 AGM highlights strategic progress in hydrogen and CO2 storage technologies, focusing on European market expansion and a refined licensing business model.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.